Renal cell carcinoma of end-stage renal disease: A histopathologic and molecular genetic study

Journal of the American Society of Nephrology

Volumn 7, Issue 11, 1996, Pages 2461-2468

  Hughson, Michael D ^a   Schmidt, Laura ^b   Zbar, Berton ^c   Daugherty, Shawn ^a   Meloni, Aurelia M ^d   Silva, Fred G ^e   Sandberg, Avery A ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Genzyme Genetics   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer genetics; ESRD; Renal cell carcinoma

Indexed keywords

DNA;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 3P; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DIALYSIS; FEMALE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY FAILURE; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0030377281     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. US Renal Data Service: 1994 annual data report. Am J Kidney Dis 1994;18:S12-S111.
2. US Renal Data System: The 1989 Report of the US Renal Data System: V. Survival probabilities and causes of death. Am J Kidney Dis 1991;18[Suppl 2]:49-60.
3. Port FK, Ragheb NE, Schwartz AG, et al.: Neoplasms in dialysis patients: A population-based study. Am J Kidney Dis 1989;14:119-123.
4. Dlugosz BA, Bretan PN, Novick AC, et al.: Causes of death in kidney transplant recipients: 1970 to present. Transplant Proc 1989;21:2168-2170.
5. Hughson MD, Buchwald D, Fox M: Renal neoplasia and acquired cystic disease in patients receiving long-term dialysis. Arch Pathol Lab Med 1986;110:592-601.
6. McDougall ML, Welling LW, Weigmann TB: Prediction of carcinoma in acquired cystic disease as a function of kidney weight. J Am Soc Nephrol 1990;1:828-831.
7. Ishikawa I: Renal carcinoma in chronic hemodialysis patients-A 1990 questionnaire study in Japan. Kidney Int 1993;34[Suppl 41]:S167.
8. Hughson MD, Hennigar GR, McManus JFA: Atypical cysts, acquired renal cystic disease, and renal cell tumors in end-stage dialysis kidneys. Lab Invest 1980;42: 475.
9. Ishikawa I, Kovacs G: High incidence of papillary renal cell tumors in patients on chronic hemodialysis. Histopathology 1993;22:135.
10. Hughson MD, Meloni AM, Dunn T, et al.: Tumorigenesis in the end-stage kidney. In: Gabow PA, Grantham JJ, Eds. Proceedings of the Fifth International Workshop on Polycystic Kidney Disease. Kansas City: Polycystic Kidney Research Foundation; 1992:94-98.
11. Thoenes W, Storkel S, Rumpelt HJ, Moll R: Cytomorphological typing of renal cell carcinoma: A new approach. Eur Urol 1990;18[lsab]Suppl 2]:6-9.
12. Medieros LT, Weiss LM: Renal adenocarcinoma. In: Eble JN, Ed. Tumors and Tumor-like Conditions of the Kidney and Ureters. Edinburgh: Churchill Livingston; 1990:35.
13. Kovacs G: Molecular cytogenetics of renal cell tumors. Adv Cancer Res 1993;62:89-124.
14. Anglard P, Tory K, Brauch H, et al.: Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 1991;51:1071-1077.
15. Latif F, Tory K, Gnarra J, et al.: Identification of the von Hipple-Lindau disease tumor suppressor gene. Science 1993;260:1317-1320.
16. Gnarra JR, Tory, Weng Y, et al.: Mutations of the VHL tumor suppressor gene in renal carcinoma. Nature Genet 1994;7:85-90.
17. Glenn GM, Choyke PL, Zbar B, et al.: von Hippie-Lindau disease. Clinical review and molecular genetics. In: Anderson EE, Ed. Problems in Urologic Surgery: Benign and Malignant Tumors of the Kidney. Philadelphia: JB Lippincott; 1990:312-330.
18. Gnarra JR, Lerman MI, Zbar B, Linehan WM: Genetics of renal-cell carcinoma and evidence for a critical role for von Hipple-Lindau in renal tumorigenesis. Semin Oncol 1995;22:3-8.
19. Shuin T, Kondo K, Torigoe S, et al.: Frequent somatic mutations and loss of heterozygosity of the von Hipple-Lindau tumor suppressor gene in primary human renal cell tumors. Cancer Res 1994;54:2852-2855.
20. Budin RE, McDonnell PJ: Renal cell neoplasms. Their relationship to arteriolonephrosclerosis. Arch Pathol Lab Med 1984;108:138-140.
21. Grantham JJ, Levine E: Acquired cystic disease: Replacing one kidney disease with another. Kidney Int 1985; 28:99-105.
22. Levine E, Slusher SL, Grantham JJ, Wetzel LH: Natural history of acquired renal cystic disease in dialysis patients: A prospective longitudinal CT study. Am J Radiol 1991;156:501-506.
23. Gardner KD, Evan AP: Cystic kidneys: An enigma evolves. Am J Kidney Dis 1984;3:403-413.
24. Gregorie JR, Torres VE, Holley KE, Farrow GM: Renal epithelial hyperplasia and neoplastic proliferation in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1987;9:27-38.
25. Ishikawa I, Onouchi Z, Saito Y, et al.: Sex differences in acquired cystic disease of the kidney on long term dialysis. Nephron 1985;39:336-340.
26. Ishikawa I, Saito Y, Shikura N, et al.: Ten-year prospective study of renal cell carcinoma in dialysis patients. Am J Kidney Dis 1990;16:452-458.
27. Levine E: Renal cell carcinoma in uremic acquired cystic disease: Incidence, detection, and management. Urol Radiol 1992;13:203-210.
28. Matson MA, Cohen EP: Acquired cystic disease: Occurrence, prevalence, and renal cancers. Medicine 1990;69: 217-226.
29. Murphy WM, Beckwith JB, Farrow GM: Tumors of the Kidney, Bladder, and Related Urinary Structures. Atlas of Tumor Pathology, Third Series, Fascicle 11. Washington DC: Armed Forces Institute of Pathology; 1994:92-131.
30. DalCin P, Gaeta J, Huben R, et al.: Renal cortical tumors. Cytogenetic characterization. Am J Clin Pathol 1989;92:408-414.
31. Kovacs G, Fugezi L, Emanuel A, Kung H-F: Cytogenetics of papillary renal cell tumors. Genes Chrom Cancer 1991;3:249-255.
32. Storkel S, van den Breg E, Cremer T: Morphologic and cytogenetic classification of epithelial renal cell tumors [Abstract]. Modern Pathol 1995;8:479.
33. Ishikawa I, Shikura N, Ozaki M: Papillary renal cell carcinoma with numeric changes of chromosomes in a long-term hemodialysis patient: A karyotype analysis. Am J Kidney Dis 1993;21:553-556.
34. Hughson MD, Meloni A, Dougherty S, et al.: Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas: Correlation with tumor karyotypes. Cancer Genet Cytogenet 1996;87:133-138.
35. Hughson MD, Meloni AM, Silva FG, Sandberg AA: Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: Cytogenetic and molecular genetic findings. Cancer Genet Cytogenet 1996;89:65-68.
36. Kovacs G: Application of molecular cytogenetic techniques to the evaluation of parenchymal renal tumors. J Cancer Res Clin Oncol 1990;116:318-323.
37. Yunis JJ: The chromosomal basis of human neoplasia. Science 1983;221:227-235.
38. Cengiz K, Block AW, Hossfeld DK, et al.: Sister chromatid exchange and chromosomal abnormalities in uremic patients. Cancer Genet Cytogenet 1988;36:55-67.
39. Kovacs G, Brusa P: Clonal chromosomal abnormalities in normal kidney tissue from patients with renal cell carcinoma. Cancer Genet Cytogenet 1989;37:289-290.
40. Casalone R, Casalone PG, Minelli E, et al.: Significance of the clonal and sporadic chromosomal abnormalities in non-neoplastic renal tissue. Hum Genet 1992;90:71-78.
41. Hughson MD, Meloni AM, Silva FG, Sandberg AA: Chromosomal abnormalities in a polycystic kidney. A mechanism for tumorigenesis in the end-stage kidney? [Abstract] Modern Pathol 1991;6:341.
42. Zbar B, Glenn G, Lubensky I, et al.: Hereditary papillary renal cell carcinoma: Clinical studies in 10 families. J Urol 1995;153:907-912.